ZA9810272B - Formulation of a cobination of a opioid and a alpha-adrenergic agonist and the use thereof - Google Patents

Formulation of a cobination of a opioid and a alpha-adrenergic agonist and the use thereof

Info

Publication number
ZA9810272B
ZA9810272B ZA9810272A ZA9810272A ZA9810272B ZA 9810272 B ZA9810272 B ZA 9810272B ZA 9810272 A ZA9810272 A ZA 9810272A ZA 9810272 A ZA9810272 A ZA 9810272A ZA 9810272 B ZA9810272 B ZA 9810272B
Authority
ZA
South Africa
Prior art keywords
cobination
opioid
alpha
formulation
adrenergic agonist
Prior art date
Application number
ZA9810272A
Other languages
English (en)
Inventor
Johannes Schneider
Johanna Korioth
Johannes Heinric Bartholomaeus
Juergen Peter Betzing
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of ZA9810272B publication Critical patent/ZA9810272B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9810272A 1997-11-11 1998-11-10 Formulation of a cobination of a opioid and a alpha-adrenergic agonist and the use thereof ZA9810272B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1997149724 DE19749724A1 (de) 1997-11-11 1997-11-11 Verwendung einer Kombination aus Opioid und alpha-adrenergem Agonisten in Schmerzmitteln

Publications (1)

Publication Number Publication Date
ZA9810272B true ZA9810272B (en) 1999-05-10

Family

ID=7848237

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9810272A ZA9810272B (en) 1997-11-11 1998-11-10 Formulation of a cobination of a opioid and a alpha-adrenergic agonist and the use thereof

Country Status (5)

Country Link
AU (1) AU1665499A (xx)
DE (2) DE19758564A1 (xx)
PE (1) PE123899A1 (xx)
WO (1) WO1999024023A2 (xx)
ZA (1) ZA9810272B (xx)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9314449B2 (en) 2011-10-14 2016-04-19 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
US9320712B2 (en) 2012-01-04 2016-04-26 Hospira, Inc. Dexmedetomidine premix formulation
US10076498B2 (en) 2006-08-25 2018-09-18 Purdue Pharma L.P. Tamper resistant dosage forms

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US7973068B2 (en) 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
EP1227807B1 (en) * 1998-10-20 2005-03-30 Omeros Corporation Irrigation solution and method for inhibition of pain and inflammation
US20030087962A1 (en) 1998-10-20 2003-05-08 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
PE20001396A1 (es) * 1999-01-18 2000-12-23 Gruenenthal Chemie Formulaciones medicamentosas retardadas que contienen una combinacion de un opioide o una sal fisiologicamente tolerables del mismo, un o-agonista
DE19938823A1 (de) * 1999-08-19 2001-02-22 Boehringer Ingelheim Pharma Medikamentöse Behandlung des Restless Leg Syndroms
PL354872A1 (en) * 1999-10-23 2004-03-08 Alkaloid Ad Oral dosage form comprising a salt of morphine or a morphine derivative
US6572891B1 (en) 1999-10-23 2003-06-03 Alkaloid Ad Sublingual oral dosage form
EP1942903A4 (en) * 2005-08-30 2011-01-12 Univ Kingston POTENTIATING THE THERAPEUTIC EFFECT OF AN OPIOID RECEPTOR AGONIST AND / OR INHIBITING OR REVERSING THE TOLERANCE FOR OPIOID RECEPTOR AGONISTS WITH A ULTRANOUS DOSE OF AN ALPHA-2 RECEPTOR ANTAGONIST
AU2008216867B2 (en) * 2007-02-09 2014-01-30 Durect Corporation Transoral dosage forms comprising sufentanil and naloxone
US20090246256A1 (en) * 2008-03-27 2009-10-01 Al-Ghananeem Abeer M Compositions and Methods for Transmucosal Delivery of Lofexidine
BR112014019171A8 (pt) 2011-12-11 2017-07-11 Recro Pharma Inc Composições intranasais de dexdetomida e seus métodos de uso
ES2614757T3 (es) 2012-05-02 2017-06-01 Orexo Ab Nueva composición de alfentanilo para el tratamiento del dolor agudo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635204A (en) * 1994-03-04 1997-06-03 Montefiore Medical Center Method for transdermal induction of anesthesia, analgesia or sedation

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11826472B2 (en) 2006-08-25 2023-11-28 Purdue Pharma L.P. Tamper resistant dosage forms
US10076498B2 (en) 2006-08-25 2018-09-18 Purdue Pharma L.P. Tamper resistant dosage forms
US10076499B2 (en) 2006-08-25 2018-09-18 Purdue Pharma L.P. Tamper resistant dosage forms
US11298322B2 (en) 2006-08-25 2022-04-12 Purdue Pharma L.P. Tamper resistant dosage forms
US11304908B2 (en) 2006-08-25 2022-04-19 Purdue Pharma L.P. Tamper resistant dosage forms
US11304909B2 (en) 2006-08-25 2022-04-19 Purdue Pharma L.P. Tamper resistant dosage forms
US11904055B2 (en) 2006-08-25 2024-02-20 Purdue Pharma L.P. Tamper resistant dosage forms
US11938225B2 (en) 2006-08-25 2024-03-26 Purdue Pharm L.P. Tamper resistant dosage forms
US11964056B1 (en) 2006-08-25 2024-04-23 Purdue Pharma L.P Tamper resistant dosage forms
US9314449B2 (en) 2011-10-14 2016-04-19 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
US9320712B2 (en) 2012-01-04 2016-04-26 Hospira, Inc. Dexmedetomidine premix formulation
US9616049B2 (en) 2012-01-04 2017-04-11 Hospira, Inc. Dexmedetomidine premix formulation
US10016396B2 (en) 2012-01-04 2018-07-10 Hospira, Inc. Dexmedetomidine premix formulation

Also Published As

Publication number Publication date
DE19749724A1 (de) 1999-06-10
DE19758564A1 (de) 1999-08-26
WO1999024023A3 (de) 1999-07-15
WO1999024023A2 (de) 1999-05-20
PE123899A1 (es) 1999-12-25
AU1665499A (en) 1999-05-31

Similar Documents

Publication Publication Date Title
HUP0102658A3 (en) Pharmaceutical composition containing opioid agonist and antagonist combination
GR3036881T3 (en) Benzamide derivatives and their use as vasopressin antagonists
EP1047426A4 (en) USE OF METHYLNALTREXONE AND RELATED COMPOUNDS
HUP9700589A2 (en) Extended release formulation containing venlaflaxine hydrochloride
ZA9810272B (en) Formulation of a cobination of a opioid and a alpha-adrenergic agonist and the use thereof
SI1132463T1 (sl) Kozmetični sestavek, ki vsebuje antagonist receptorjev nevropeptida Y
PL337781A1 (en) Antagonists and reverse antagonists of glucogene
ZA985096B (en) Composition compound and use
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
IL123647A0 (en) Substituted amino compounds their preparation and use
HUP0100935A3 (en) Synergetic fungicidal mixture comprising an amide compound and its use
PL342400A1 (en) Fungicidal mixtures based on amidic compounds and derivatives of piperidine
IL141050A0 (en) Muscarinic agonists and antagonists
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
HUP0101132A3 (en) Synergetic fungicidal mixture containing an amide compound and its use
PL328633A1 (en) Oxazolic and thiadizolic antagonists of muscarinic receptors
HUP0003039A3 (en) Synergistic fungicidal mixture and use thereof
HUP0002765A3 (en) Synergic fungicidal mixtures and use thereof
ZA9811346B (en) Substituted heterocyclic benzocycloalkenes and their use as an analgesic
ZA989238B (en) Benzimidazole compounds pharmaceutical compositions containing the compounds and their use
AU7186994A (en) Phenyrrole derivatives and their use as dopamine d3 antagonists
HUP0001935A3 (en) Fungicidal compositions containing quinazolinone derivative and use thereof
AUPP672198A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
HUP0100544A3 (en) Synergetic fungicidal mixture comprising amide compound quinolinyl-phenyl-ether derivatives and its use
HUP0002791A3 (en) Synergistic fungicidal mixture and use thereof